InvestorsHub Logo
Followers 834
Posts 119875
Boards Moderated 17
Alias Born 09/05/2002

Re: None

Friday, 06/08/2012 8:27:05 AM

Friday, June 08, 2012 8:27:05 AM

Post# of 121
FDA extends NDA review of NVO’s degludec and degludecplus by three months:

#msg-6408031

The new PDUFA date for both products is 10/29/12.

These drugs are NVO's attempt to compete with SNY's blockbuster, Lantus.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNY News